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Summary: We describe sequence analysis of the mitochondrial DNA of ¢ve
Hungarian patients diagnosed with probable LHON, who do not carry any
of the three primary point mutations. We report three novel mutations, one
of which might have a pathogenic role.
Leber hereditary optic neuropathy (LHON) is a maternally inherited disease charac-
terized by a subacute, sequential, bilateral loss of central vision. The vast majority of
LHON cases are associated with one of the three primary point mutations at
nucleotide positions np11778, np3460 and npl4484 of the mitochondrial DNA
(mtDNA).
In this report, we describe the sequencing analysis of the mtDNA of ¢ve
Hungarian patients (H1^H5) who were diagnosed with probable LHON but were
tested negative for the three primary point mutations. H1 and H2 are siblings while
the three other patients have no family history.
We have sequenced all the complex I genes of the mtDNA of patients H1, H3, H4
and H5. For patients H1 and H5 we extended our sequencing analysis to the
cytochrome-c oxidase (COX) I, COX II, COX III, and the cytochrome b (Cytb)
genes (Anderson et al 1981).
The DNAs had been isolated from total blood using a standard protocol of salt
precipitation and were ampli¢ed using standard PCR conditions. The sequencing
was performed on a polyacrylamide gel using an ABI 377 automated sequencer.
For the identi¢ed novel mutation at np10237 we created a restriction digest test
with AseI.
We found that patient H3 carries a C-to-A transition at npl3735 of the ND5 gene
leading to a replacement of a nonconserved leucine by an isoleucine (Leu467Ile).
Sequencing the complex I genes of patient H4 revealed a few silent mutations only.
Patient H5 was found to carry the sequence variations characteristic of the European
haplogroup J. In addition, he carries a homoplasmic C-to-T transition at np10192
that results in a replacement of a not very conserved serine by a phenylalanine
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residue at codon 45 of the ND3 gene (Ser45Phe) (Fearnley and Walker 1992). The
pathogenic role of these mutations in LHON does not seem to be likely (Huoponen
et al 1993).
Our most remarkable ¢nding is a homoplasmic T-to-C transition at np10237 of
the ND3 gene of patients H1 and H2 resulting in a substitution of an isoleucine
with a threonine residue (Ile59Thr). It occurs in a very conserved region of the
ND3 gene, in a potential membran-spanning a-helix. The isoleucine at this position
is highly conserved: other species carry lle, Leu or Val at this position and these
are all amino acids with a hydrophobic side-chain (Fearnley and Walker 1992).
Threonine, however, has an aliphatic hydroxyl side-chain. The mutation is also pre-
sent in homoplasmic form in the mother and maternal aunt of patients H1 and
H2 but was not found in the 85 control DNA samples from the same ethnic
background, and was also absent in a control group of 100 DNA samples studied
recently by R. Horvath (personal communication). Apart from the mutation
l0237T>C, patients H1 and H2 carry some previously identi¢ed polymorphisms that
are not suspected to have a pathogenic role. Since we have no knowledge of other
a¡ected family members we cannot rule out the possibility of a recessive optic atro-
phy in this case. Still the mutation 10237T>C deserves attention. Biochemical
studies and further data about its occurrence in LHON and control populations
can determine its role in the pathogenesis of LHON.
REFERENCES
Anderson S, Bankier AT, Barrell BG, et al (1981) Sequence and organisation of the human
mitochondrial genome. Nature 290: 457^465.
Fearnley IM, Walker JE (1992) Conservation of sequences of subunits of mitochondrial
complex I and their relationship with other proteins. Biochim Biophys Acta 1140: 105^134.
Huoponen K, Lamminen T, Juvonen V, Aula P, Nikoskelainen E, Savontaus ML (1993) The
spectrum of mitochondrial DNA mutations in families with Leber hereditary optic
neuroretinopathy. Hum Genet 92: 379^384.
324 Short Report
J. Inherit. Metab. Dis. 25 (2002)
